Hainan Haiyao (000566) According to the interactive platform, the company's subsidiary Shanghai Youcadi Biomedical Technology Co., Ltd. submitted more than 30 invention patents related to CAR-T technology, ranking first among domestic peers, and upgraded CAR-T technology and developed multiple products. A small RNA silencing technology targeting interleukin 6 was designed on the CAR carrier, while not affecting the clinical treatment effect, while reducing the risk caused by the cytokine storm. This design was the first application at home and abroad. The related products completed hundreds of clinical research cases of haematological cancer CAR-T and achieved good expected results .
海南海药：子公司小RNA沉默技术设计属国内外首次应用
Hainan Haiyao: The subsidiary's small RNA silencing technology design was applied for the first time at home and abroad
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.